Related Experiment Videos
OCRx: Canadian Drug Ontology
Jean Noel Nikiema1,2, Man Qing Liang1,2, Philippe Després3
1Research Center, Centre hospitalier de l'Université de Montréal, Montréal, Canada.
Studies in Health Technology and Informatics
|May 27, 2021
Summary
A new Canadian drug ontology (OCRx) was developed to standardize drug information for electronic health records. This ontology improves data usability and interoperability, aligning with international standards.
Area of Science:
- Pharmacology
- Health Informatics
- Ontology Engineering
Background:
- Drug terminologies require normalization and standardization for effective use in electronic health records.
- Existing drug information systems may lack interoperability, hindering data exchange and access.
- Canadian drug data needs a standardized representation aligned with international norms.
Purpose of the Study:
- To develop and evaluate a Canadian drug ontology (OCRx) for standardized drug descriptions.
- To enhance the usability and interoperability of drug terminologies within electronic health record systems.
- To provide non-ambiguous access to drug information.
Main Methods:
- Development of the Canadian drug ontology (OCRx) using Web Ontology Language.
- Alignment of OCRx with the Identification of Medicinal Product (IDMP) standards.
- Mapping of OCRx to RxNorm for comparative analysis.
Main Results:
- The first release of OCRx has been developed and described.
- OCRx is aligned with IDMP standards, facilitating international data consistency.
- Mapping to RxNorm provides a comparative benchmark against a US drug terminology.
Conclusions:
- OCRx offers a standardized and normalized description of Canadian-authorized drugs.
- The ontology enhances drug information accessibility and interoperability in health records.
- OCRx serves as a foundational resource for improving drug data management in Canada.